Health TrialsbyHealthPanel

Neuropathic Pain, Catastrophizing, and Adherence in SAIS

ConditionSubacromial Impingement Syndrome
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-65
SponsorAbant Izzet Baysal University

About this trial

Subacromial impingement syndrome is one of the most common causes of shoulder pain and may negatively affect daily activities and quality of life. While shoulder pain is usually considered nociceptive, some patients may also have a neuropathic pain component, which can influence symptom severity and treatment outcomes. In addition, psychological factors such as pain catastrophizing and adherence-related behavior may play an important role in recovery.

This prospective observational study aims to evaluate the presence of neuropathic pain in patients with subacromial impingement syndrome and to investigate its relationship with pain catastrophizing and adherence-related behavior. Patients undergoing a standard physical therapy program will be assessed at the beginning and after completion of treatment using validated clinical scales.

The findings of this study may help to better understand the interaction between pain characteristics, psychological factors, and adherence-related behavior, and contribute to the development of more individualized rehabilitation strategies

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Unilateral subacromial impingement syndrome lasting at least 3 months

Planned to start a 10-session physical therapy program

Willing and able to provide informed consent

Disqualifiers

Upper extremity entrapment neuropathy or polyneuropathy

History of diabetes mellitus

Inflammatory rheumatic disease, infection, or malignancy

Frozen shoulder

Trial population

The study population consists of adult patients aged 18-65 years diagnosed with unilateral subacromial impingement syndrome who are referred to an outpatient physical therapy and rehabilitation clinic. Patients with symptoms lasting at least three months. Participants scheduled to undergo a standard conservative physical therapy program will be included.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Standard Conservative Physical Therapy

    Other intervention

    Participants receive a standard conservative physical therapy program as part of routine clinical care. No experimental or study-assigned intervention is applied within the scope of this study.

Treatment groups

75 Participants
are divided into 1 treatment group
Group A: Patients with Subacromial Impingement Syndrome1 intervention

Trial outcomes

Primary outcomes

1

Neuropathic Pain Component (DN4)

Neuropathic pain will be assessed using the Douleur Neuropathique 4 Questions (DN4). Total scores range from 0 to 10, with higher scores indicating a greater neuropathic pain component. A score of ≥4 will be considered indicative of neuropathic pain

Time frame
Baseline and 2 weeks
2

Pain Catastrophizing (PCS)

Pain catastrophizing will be assessed using the Pain Catastrophizing Scale. Total scores range from 0 to 52, with higher scores indicating greater catastrophizing.

Time frame
Baseline and 2 weeks

Secondary outcomes

1

Pain Intensity at Rest (VAS)

Pain intensity at rest will be assessed using the Visual Analog Scale (VAS). Scores range from 0 to 10, with higher scores indicating greater pain intensity.

Time frame
Baseline and 2 weeks
2

Pain Intensity During Activity (VAS)

Pain intensity during activity will be assessed using the Visual Analog Scale (VAS). Scores range from 0 to 10, with higher scores indicating greater pain intensity.

Time frame
Baseline and 2 weeks
3

Pain Intensity at Night (VAS)

Night pain intensity will be assessed using the Visual Analog Scale (VAS). Scores range from 0 to 10, with higher scores indicating greater pain intensity.

Time frame
Baseline and 2 weeks
4

Functional Status (DASH)

Functional status will be assessed using the Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire. Scores range from 0 to 100, with higher scores indicating greater disability.

Time frame
Baseline and 2 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Abant Izzet Baysal University

Lead sponsor

Source ClinicalTrials.gov
Apply now